Structuring the Added Value of Biomedicine Products in the Innovative Economy

In modern conditions, biomedicine, as a priority sector of the innovation economy, is developing dynamically, due to the desire of the world community to increase the quality of life, duration, financial security, and social well-being. The basis of the structuring of biomedical products is a step-by-step process of transformation of the scientific idea and innovative project into the final product of the industry, having a value assessment and high practical relevance to all stakeholders. One of the criteria of success of an innovative product is the indicator of added value. The aim of the research is to determine the multi-element composition of added value of innovative products in biomedicine and develop its gradual structuring on the basis of a generalization of modern domestic and world level research. The article analyzes the specific structure of biomedicine products, reveals the essence of added value as an indicator integrating assessment and analytical procedures that determine the importance and relevance of a particular biomedical product for the population, government, business community, as well as the degree of need for its early development, approbation, and implementation. A step-by-step structuring of the value added of biomedicine products has been developed and its element-wise composition has been evaluated. Practical significance of which lies in the possibility of making alternative choices at the government level for investment purposes and at the business community level in order to introduce the most promising option from the point of view of mass production and obtaining the maximum socio-economic and financial effect.